Polyrizon携手全球领先临床前CRO,加速推进临床开发项目

美股速递
Mar 17

Polyrizon Ltd. (PLRZ) 已与一家全球顶尖的临床前合同研究组织(CRO)正式签署合作协议,此举是其整体临床开发计划中的关键一步。

该合作旨在利用该CRO在临床前研究领域的专业能力和全球资源,以推进Polyrizon研发管线的进展。协议的签署标志着公司向临床阶段迈出了实质性的一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10